Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Maruyama

Showing results (171-180 of 389) with videos related to

Pageof 39
Sort By:
Biomaterials|May 10, 2014
Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosisSaori Nagao, Kazuaki Taguchi, Hiromi Sakai, et al.
Journal of Pharmaceutical Sciences|March 11, 2015
Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat ModelKazuaki Taguchi, Mai Hashimoto, Shigeru Ogaki, et al.
Molecular Pharmaceutics|June 11, 2024
Contribution of the α<sub>1</sub>-Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α<sub>1</sub>-Acid Glycoprotein-Knockout MiceYuka Nakamura, Hiroshi Watanabe, Tadashi Imafuku, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 2005
Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndromeNorito Takamura, Toru Maruyama, Etsuo Chosa, et al.
Pharmaceutical Research|May 23, 2006
Recombinant human serum albumin dimer has high blood circulation activity and low vascular permeability in comparison with native human serum albuminSadaharu Matsushita, Victor Tuan Giam Chuang, Masanori Kanazawa, et al.
Scientific Reports|November 27, 2020
Systemic and sustained thioredoxin analogue prevents acute kidney injury and its-associated distant organ damage in renal ischemia reperfusion injury miceKento Nishida, Hiroshi Watanabe, Masako Miyahisa, et al.
The Journal of Biological Chemistry|July 19, 2012
α(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stressHisakazu Komori, Hiroshi Watanabe, Tsuyoshi Shuto, et al.
Biochimica Et Biophysica Acta|November 22, 2007
Changes of net charge and alpha-helical content affect the pharmacokinetic properties of human serum albuminYasunori Iwao, Mikako Hiraike, Ulrich Kragh-Hansen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 2012
Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal modelsYu Ishima, Marie Hara, Ulrich Kragh-Hansen, et al.
Bioconjugate Chemistry|January 10, 2012
S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effectsYu Ishima, Di Chen, Jun Fang, et al.
Pageof 39

Showing results (171-180 of 389) with videos related to

Sort By:
Pageof 39
Biomaterials|May 10, 2014
Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosisSaori Nagao, Kazuaki Taguchi, Hiromi Sakai, et al.
Journal of Pharmaceutical Sciences|March 11, 2015
Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat ModelKazuaki Taguchi, Mai Hashimoto, Shigeru Ogaki, et al.
Molecular Pharmaceutics|June 11, 2024
Contribution of the α<sub>1</sub>-Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α<sub>1</sub>-Acid Glycoprotein-Knockout MiceYuka Nakamura, Hiroshi Watanabe, Tadashi Imafuku, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 2005
Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndromeNorito Takamura, Toru Maruyama, Etsuo Chosa, et al.
Pharmaceutical Research|May 23, 2006
Recombinant human serum albumin dimer has high blood circulation activity and low vascular permeability in comparison with native human serum albuminSadaharu Matsushita, Victor Tuan Giam Chuang, Masanori Kanazawa, et al.
Scientific Reports|November 27, 2020
Systemic and sustained thioredoxin analogue prevents acute kidney injury and its-associated distant organ damage in renal ischemia reperfusion injury miceKento Nishida, Hiroshi Watanabe, Masako Miyahisa, et al.
The Journal of Biological Chemistry|July 19, 2012
α(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stressHisakazu Komori, Hiroshi Watanabe, Tsuyoshi Shuto, et al.
Biochimica Et Biophysica Acta|November 22, 2007
Changes of net charge and alpha-helical content affect the pharmacokinetic properties of human serum albuminYasunori Iwao, Mikako Hiraike, Ulrich Kragh-Hansen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 2012
Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal modelsYu Ishima, Marie Hara, Ulrich Kragh-Hansen, et al.
Bioconjugate Chemistry|January 10, 2012
S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effectsYu Ishima, Di Chen, Jun Fang, et al.
Pageof 39